Skip to nav Skip to content
Facebook Twitter LinkedIn Email

CID/JID/OFID Manuscript Review Program

The Infectious Diseases Society of America offers category 1 CME credit for reviewing manuscripts. Only reviews received on time and judged satisfactory by the Editor(s) responsible for the particular manuscript will be eligible for CME credit. We only provide CME credit to reviewers if they request CME credit at the time they complete their review.

The features that contribute most importantly to the quality of manuscript reviews for the Journal include: adherence to reviewer guidelines, specificity and accuracy, completeness, usefulness of recommendations to both editors and authors, tone, internal consistency, and mindfulness of the needs of our readers and the medical community as a whole.

To prepare a high quality review, the reviewer should consider existing evidence when preparing his or her comments. The reviewer should place the current work in the context of existing evidence in the area, describe the unique contributions of the current work, and comment on any inconsistencies of the current work with previous research in your area.

You will be notified via email if your review of the assigned manuscript was completed on time and if it met our criteria for CME credit.

Accreditation Statement

The Infectious Diseases Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  IDSA designates each manuscript review for a maximum of 3 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.  Physicians are eligible for up to 3 CME credits for each manuscript review, up to a total of 15 per year.


Through the manuscript peer review process for CID, JID, or OFID, you should be able to:

  • integrate new discoveries or observations in infectious disease research that can be applied in your work
  • use information resources that improve your ability to treat patients or to conduct research in infectious diseases
  • identify articles that provide relevant, new data about infectious diseases that could result in additional knowledge
  • apply new information that could result in improved healthcare outcomes

Disclosure Information 

In compliance with ACCME’s Standards for Commercial Support of Continuing Medical Education, anyone in a position to influence content is required to disclose any real or apparent conflicts of interest before participating in a CME-accredited educational activity. IDSA, in collaboration with CID, JID and OFID, identifies and resolves all conflicts of interest prior to manuscript reviews.

Name Title Disclosure Advisory/Consultant Expert Testimony Honoraria Ownership Interests Stocks/Bonds Patent/Copyright/License Other Renumeration Research Grants/Contracts Organizational Benefit Activities with Other Organizations Family or Other Relations
Paul E. Sax Editor-in-Chief -- Gilead, Janssen, Merck, ViiV/GSK -- -- -- -- -- -- NIH, Gilead, ViiV/GSK -- UpToDate --
Kimberly Hanson Deputy Editor -- Pfizer, Takeda, Quidel, Health TrackRX -- -- -- -- -- -- NIH -- CLSI, ASM, ABIM --
David A. Pegues Deputy Editor -- DaVita/Total Renal Care, Alexion Pharmaceuticals, ATYU Bioscience, IKEA -- -- -- -- -- -- AHRQ, PDI Healthcare, NIAID/NIH -- -- --
Maunank Shah Deputy Editor -- -- -- -- -- -- Emocha Mobile Health   NIH -- National Society of Tuberculosis --
Jose R. Arribas Associate Editor -- Gilead, Janssen, Theranos, Sobi, Aelix,
Lilly, Astra Zeneca, MSD, Serono, Roche, Sobi, Pfizer, MSD, GSK, ViiV
-- -- -- -- -- MSD, GSK, ViiV Gilead, ViiV, MSD, Janssen, Roche, Seronoe, HIPRA -- -- --
Sara Hurtado Bares Associate Editor -- -- Gilead Sciences -- -- -- --   ViiV Healthcare, Janssen -- -- --
Taison Bell Associate Editor -- -- -- -- Owl Peaks Labs -- --     -- ATS Scholar --
Jose R. Castillo-Mancilla Associate Editor -- -- -- -- -- -- -- Practice Point CME NIH/NIAID, Gilead Sciences -- -- --
Christina Coyle Associate Editor Nothing to disclose -- -- -- -- -- --   -- -- -- --
Jason Gallagher Associate Editor -- Merck, Spero, Astellas, Shionogi -- Merck, Spero, Astellas, Shionogi -- -- -- -- Merck -- -- --
Rajesh T. Gandhi Associate Editor Nothing to disclose -- -- -- -- -- -- -- NIH -- -- --
Emily L. Heil Associate Editor Nothing to disclose Wolters Kluwer (Lexi-Comp) -- -- -- -- -- -- Maryland Department of Health -- Society of Infectious Diseases Pharmacists --
Romney Humphries Associate Editor -- Pattern, Qiagen, Torus, Roche, Specific Diagnostics -- -- -- Qiagen, Specific Diagnostics -- -- Qiagen, bioMerieux, Momentum Diagnostics, Specific Diagnostics -- ASM, CLSI, CAP --
Kerry LaPlante Associate Editor -- Melinta Therapeutics, Ferring Pharmaceuticals Inc. -- -- -- -- -- -- Merck, Gilead, NIH, Abbvie -- MADID, Pharmacotherapy, Infectious Disease and Therapy --
Ruvandhi Nathavitharana Associate Editor Nothing to disclose World Health Organization -- -- -- -- -- -- NIH/NIAID, ASTMH -- TB Proof --
Luis Ostrosky-Zeichner Associate Editor -- Cidara, Appillii, Iterum, GigaGen, Takeda, Merck, Octapharma, GSK, F2G -- -- -- -- -- Teva, Stendhal, BSAC, Pfizer, Biotoscana Scynexis, Pfizer, Pulmocide, Gilead, NIH -- ASM, Mycoses Study Group, Immunocompromised Host Society --
Jean-Jacques Parienti Associate Editor for Supplements  -- Gilead, MSD, ViiV -- -- -- -- -- -- Gilead, MSD -- -- --
Federico Perez Associate Editor -- -- -- -- -- -- -- -- Merck, Pfizer, Veterans Health Administration -- VA Society of Practitioners of Infectious Diseases --
Adam J. Ratner Associate Editor Nothing to disclose -- -- -- -- -- -- Penguin Random House NIH, CDC Foundation -- Pediatric Infectious Diseases Society, American Academy of Pediatrics --
Chanu Rhee Associate Editor -- Pfizer, Cytovale -- -- -- -- -- UpToDate Inc. AHRQ, CDC -- Society for Critical Care Medicine --
Nadine Rouphael Associate Editor -- EMMES, ICON -- -- -- -- -- -- NIH, CDC, Sanofi, Merck, Quidel, Lilly -- Vaccines, iScience, ARLG Siemens
Michael J. Rybak Associate Editor -- Merck, Abbvie, Shionogi, T2 Bioscience -- -- -- -- -- -- NIH, Merck, Tetraphase, T2 Wayne State University -- --
Ilan S. Schwartz Associate Editor -- -- -- Mycoses Study Group Education and Research Consortium, AVIR Pharma Inc. -- -- -- -- Canadian Institutes of Health Research, Northern Alberta Clinical Trials & Research Centre, F2G -- Mycoses Study Group Education & Research Consortium, Mycoses, Journal of the Association of Medical Microbiology and Infectious Diseases of Canada --
Monica Slavin  Associate Editor -- Gilead, Pfizer, F2G, Takeda, Roche -- -- -- -- -- Pfizer, Merck F2G, NHMRC, Merck -- -- --
Allan Tunkel State-of-the-Art Reviews Editor Nothing to disclose -- -- -- -- -- -- -- -- -- -- --
Tara Vijayan State-of-the-Art Reviews Editor Nothing to disclose -- -- -- -- -- -- -- -- -- -- --

JID Editors Conflict of Interest Disclosures


Martin Hirsch: Nothing to disclose

Deputy Editor

David Hooper: Consultant: Macrolide Pharmaceuticals, Shionogi, Melinta Therapeutics, Selux  Diagnostics, Bacterioscan,  Cepheid

Associate Editors

Ann Arvin: Nothing to disclose

Marcel Behr: Nothing to disclose

Raymond Chung: Research Grants: Gilead, BMS, Janssen, Abbvie, Merck, Boehringer Ingelheim; Other: Alnylam

Peter Densen: Personal Fees: Achillion, Ionis

Joseph Kovacs:  Personal Fees: Healthcare Infection Society; Non-financial support: Merck; Other: Matinas, Inc; Patent related to Pneumocystis and IL-2 in HIV infection with royalties paid

Daniel Kuritzkes: Personal Fees: Abivax, Bionor, Bristol-Myers Squibb, CytoDyn, GlaxoSmithKline, ViroStatics, InnaVirVax, Teva, Seres, Roche, Oncolys, United Bio-Pharma; Research grants and personal fees: Gilead, Merck, ViiV, Research grants: Janssen, Palisades Therapeutics

Stuart Levitz: Nothing to disclose

William Schaffner: Personal Fees: Merck, Pfizer, Dynavax, Seqirus, SutroVax, Shionogi

Jane Schwebke, Research Grants and Personal Fees: Hologic, Symbiomix, Scynexis, Toltec Pharmaceuticals, StarPharma; Research grants: BD Diagnostics, Curatek, Viamet, Gage Pharmaceuticals

Frederick Southwick: Nothing to disclose 

Peter Weller: Nothing to disclose

Richard Whitley: Personal Fees: Merck, Glaxo Smith Kline, George Washington University CME Department, American Academy of Pediatrics-South Carolina Chapter; Other: Gilead Sciences, Inc., Kite-A Gilead Company

Statistical Editors

Daniel Caffrey: Nothing to disclose

Michael Hughes: Nothing to disclose

Sarah Walker: Nothing to disclose

Name Title Disclosure Advisory/Consultant Honoraria Other Renumeration Research Grants/Contracts
John W. Baddley Interim Co-Editor-in-Chief -- Pfizer, Lilly, R-Pharm, Horizon Therapeutics, Novo Norodisk -- -- ContraFect Corporation
Andrej Spec Interim Co-Editor-in-Chief -- -- -- -- Mayne, Astellas
Obinna Nnedu Associate Deputy Editor for Transfers Nothing to disclose -- -- -- --
Samuel Aitken Associate Editor -- GlaxoSmithKline, Shionogi, Entasis Therapeutics -- -- --
Sandra Arnold Associate Editor -- -- -- -- Pfizer, Enanta Pharmaceuticals, Regeneron
Joshua Barocas Associate Editor -- Emed -- -- --
Roger J. Bedimo Associate Editor -- Merck & Co., Gilead Sciences, Janssen, ViiV Healthcare -- -- Gilead Sciences, Merck & Co.
Donald Forthal Associate Editor Nothing to disclose -- -- -- --
Inge Gyssens Associate Editor Nothing to disclose -- -- -- --
Hannah Imlay Associate Editor Nothing to disclose -- -- -- --
Colleen Kelley Associate Editor -- -- -- -- Moderna, Novavax, Gilead Sciences, Humanigen, ViiV
Monica V. Mahoney Associate Editor -- Melinta, Merck, Spero, Medicines Company Paratek, Tetraphase, Cepheid Cepheid Merck
Carlos Mejia-Chew Associate Editor Nothing to disclose -- -- -- --
Dylan Pillai Associate Editor Nothing to disclose -- -- -- --
Carlos Seas Associate Editor -- Medicago Pfizer, Merck Sharp and Dohme -- --
Laila Woc-Colburn Associate Editor -- -- -- Pri-Med --
Darcy Wooten Associate Editor -- -- -- -- --

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.